Monografie
Development of a novel human matrix for the generation of dopaminergic neurons suitable for cell-based therapy in Parkinson’s disease patients
- Sprache
-
Englisch
- Identifier
-
1186256559
- Thema
-
Therapeutics; Dopaminergic neurons; Patients; Cells
- Beteiligte Personen und Organisationen
-
Bäcker, Theresa
Wurst, Wolfgang
Wurst, Wolfgang
Schnieke, Angelika
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:58 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Bäcker, Theresa
- Wurst, Wolfgang
- Wurst, Wolfgang
- Schnieke, Angelika
Ähnliche Objekte (12)
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Dopaminergic treatment strategies for people with Parkinson’s disease in Europe: a retrospective analysis of PRISM trial data
Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
Tissue engineering for reconstructing the central dopaminergic nigro-striatal pathway in Parkinson’s disease: Cutting edge cell culture studies
Tissue engineering for reconstructing the central dopaminergic nigro-striatal pathway in Parkinson’s disease: Cutting edge cell culture studies
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Identification of genetic risk factors for Parkinson’s disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Dopaminergic treatment strategies for people with Parkinson’s disease in Europe: a retrospective analysis of PRISM trial data
Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
Tissue engineering for reconstructing the central dopaminergic nigro-striatal pathway in Parkinson’s disease: Cutting edge cell culture studies
Tissue engineering for reconstructing the central dopaminergic nigro-striatal pathway in Parkinson’s disease: Cutting edge cell culture studies
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Identification of genetic risk factors for Parkinson’s disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Dopaminergic treatment strategies for people with Parkinson’s disease in Europe: a retrospective analysis of PRISM trial data
Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
Tissue engineering for reconstructing the central dopaminergic nigro-striatal pathway in Parkinson’s disease: Cutting edge cell culture studies
Tissue engineering for reconstructing the central dopaminergic nigro-striatal pathway in Parkinson’s disease: Cutting edge cell culture studies
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Identification of genetic risk factors for Parkinson’s disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease